World’s Best-Selling Med; Cost-Effectiveness of GLP-1 Drugs; TED Drug Heads to FDA

(MedPage Today) — The GLP-1 receptor agonist tirzepatide (Zepbound, Mounjaro) surpassed the cancer immunotherapy drug pembrolizumab (Keytruda) as the world’s best-selling medicine. (STAT)
An Institute for Clinical and Economic Review report concluded…